| Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
|---|
| Etelcalcetide | hsa00600 | Sphingolipid metabolism | 4.56E-02 | 3 | Q9BX95, Q06136, P06280 | SGPP1, FVT1, GLA | More | | | Etelcalcetide | hsa03013 | RNA transport | 1.91E-02 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | | Etelcalcetide | hsa04064 | NF-kappa B signaling pathway | 2.83E-02 | 8 | P10415, Q13489, O00463, Q13546, Q9UDY8, Q13077, Q16548, P24522 | BCL2, BIRC3, TRAF5, RIPK1, MALT1, TRAF1, BCL2A1, GADD45A | More | | | Etelcalcetide | hsa04071 | Sphingolipid signaling pathway | 1.03E-02 | 6 | P21453, Q9H228, Q16537, Q9BX95, Q16539, P10415 | S1PR1, EDG8, PPP2R5E, SGPP1, MAPK14, BCL2 | More | | | Etelcalcetide | hsa04613 | Neutrophil extracellular trap formation | 7.45E-03 | 12 | O60603, P05164, P08246, Q9UM07, Q92769, Q6FI13, Q15080, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, HDAC2, H2AC18; H2AC19, NCF4, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | | Etelcalcetide | hsa04668 | TNF signaling pathway | 4.96E-02 | 6 | O00463, Q13546, Q13489, Q16539, Q13077, P14780 | TRAF5, RIPK1, BIRC3, MAPK14, TRAF1, MMP9 | More | | | Etelcalcetide | hsa05202 | Transcriptional misregulation in cancer | 1.61E-03 | 13 | Q15532, P41732, P14780, P27930, Q16548, Q13489, Q13077, P35226, P05164, P08246, Q9C0K0, Q92769, P24522 | SS18, TSPAN7, MMP9, IL1R2, BCL2A1, BIRC3, TRAF1, BMI1, MPO, ELA2, BCL11B, HDAC2, GADD45A | More | | | Etelcalcetide | hsa05217 | Basal cell carcinoma | 2.01E-02 | 4 | Q13635, P04628, Q9UJU2, P24522 | PTCH1, WNT1, LEF1, GADD45A | More | |
|
